1-2 of 2
Heather K. Raymon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies

Emanuela Dylgjeri, Christopher McNair, Jonathan F. Goodwin, Heather K. Raymon, Peter A. McCue, Ayesha A. Shafi, Benjamin E. Leiby, Renée de Leeuw, Vishal Kothari, Jennifer J. McCann, Amy C. Mandigo, Saswati N. Chand, Matthew J. Schiewer, Lucas J. Brand, Irina Vasilevskaya, Nicolas Gordon, Talya S. Laufer, Leonard G. Gomella, Costas D. Lallas, Edouard J. Trabulsi, Felix Y. Feng, Ellen H. Filvaroff, Kristin Hege, Dana Rathkopf, Karen E. Knudsen
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (18): 5623–5637.
https://doi.org/10.1158/1078-0432.CCR-18-2207
Published: 13 September 2019
View article titled, Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies
Open the PDF for Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies in another window
Includes: Supplementary data
Journal Articles

The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas

Beatrice Gini, Ciro Zanca, Deliang Guo, Tomoo Matsutani, Kenta Masui, Shiro Ikegami, Huijun Yang, David Nathanson, Genaro R. Villa, David Shackelford, Shaojun Zhu, Kazuhiro Tanaka, Ivan Babic, David Akhavan, Kelly Lin, Alvaro Assuncao, Yuchao Gu, Bruno Bonetti, Deborah S. Mortensen, Shuichan Xu, Heather K. Raymon, Webster K. Cavenee, Frank B. Furnari, C. David James, Guido Kroemer, James R. Heath, Kristen Hege, Rajesh Chopra, Timothy F. Cloughesy, Paul S. Mischel
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (20): 5722–5732.
https://doi.org/10.1158/1078-0432.CCR-13-0527
Published: 14 October 2013
View article titled, The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas
Open the PDF for The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas in another window
Includes: Supplementary data